Results From the OPTION Trial: Oral Anticoagulation Compared to LAA Closure

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
To learn about Atrial Fibrillation Stroke Prevention Center at Cleveland Clinic, please visit https://cle.clinic/40xpCd0

A Cleveland Clinic-led trial found that a minimally-invasive procedure – left atrial appendage (LAA) closure – resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to oral anticoagulation, while preserving low rates of stroke, blood clots and death. The OPTION Trial was presented at the American Heart Association’s Scientific Sessions 2024. Walid Saliba, MD, speaks with Oussama Wazni, MD, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic and Primary Investigator of the OPTION Trial about the results of the trial and implications for practice.

For more information about our experts:
Dr. Saliba - https://cle.clinic/38GbEgs
Dr. Wazni - https://cle.clinic/3O5putb

If you liked the video hit like and subscribe for more!
#clevelandclinic #cardiacconsult
Category
Cardiology
Be the first to comment

Up Next